MDAI (5,6-methylenedioxy-2-aminoindane) is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non-neurotoxic and highly selective serotonin releasing agent (SSRA) in vitro and produces entactogen effects in humans.
^Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
MDAI (5,6-methylenedioxy-2-aminoindane) is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non-neurotoxic...
5-APB, 5-MAPB, 6-APB, 6-MAPB, methylone, mephedrone, GHB, αMT, and αET, MDAI among others. Most entactogens are phenethylamines and amphetamines, although...
may be useful for psychotherapeutic applications. It is closely related to MDAI but with the benzodioxole ring system replaced by benzofuran. 6-APB 5-MAPB...
derivatives of other empathogen-entactogens such as MDMA and MDA. Examples include MDAI and MDMAI. Nichols also created an indane isomer of amphetamine, 2-aminoindane...
derivative of MDAT, similarly to the relationship of MDMA to MDA or MDMAI to MDAI. 2-Aminotetralin Violland R, Violland-Duperret N, Pacheco H, Trouiller G...
IV 293 dates to 69 BC. The others are IGR IV 294, IPergamon II 256, and MDAI(A) 35, p. 409, no. 3, which cannot be precisely dated, but all belong around...
also known as 'EBDP' Methyl-K, also known as 'MBDP' and 'UWA-91' IDNNA Iris MDAI MDMAI MDAT MDMAT MDAL MDBU MDBZ MDDM MDIP MDMEOET MDMEO MDOH, also known...
Global Information
